HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bruce Keogh Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Keogh, B. Search for Related Content PubMed Articles by Keogh, B.

Eur J Cardiothorac Surg 2004;26:S1
© 2004 Elsevier Science NL

Foreword

Symposium for the Future of Cardiac Surgery

University College London, The Heart Hospital, 16–18 Westmoreland Street, London W1G 8PH, UKSecretary General,European Association for Cardio-Thoracic Surgery

^* Tel./fax: +44 20 7573 8888 (Email: secretary@eacts.norrnod.se).

The first 20% of the full text of this article appears below.

Cardiac surgeons are entering turbulent times. Until recently the specialty had enjoyed unparalleled expansion as the demand for effective cardiac revascularisation exploded. The randomised trials of the 1970s coupled with advances in myocardial protection fuelled our belief in the supremacy of surgery as a revascularisation strategy. We were unassailable. Then in the late 1970s the crazy concept of balloon angioplasty emerged from the mountains of Switzerland. Before long commercial interests took hold, new technology emerged and evidence accrued that percutaneous transluminal coronary angioplasty worked well in selected cases. Surgeons observed from the sidelines as a series . . . [Full Text of this Article]